On February 25, 2026, GSK reached an agreement to acquire the Canadian biotech firm 35Pharma for $950 million. The centerpiece... Read more
GSK acquires 35Pharma to challenge for leadership in pulmonary hypertension market
26/02/2026
Published by vivi
